US Healthcare Still Stupidly Expensive, With Pathetic Outcomes, Study Finds

The latest cross-national comparison of 20 high-income countries confirms what every American already suspects in their gut: the US healthcare system remains a spectacular money pit that delivers worse results than systems in peer nations. Americans fork over far more cash for care that kills people earlier and leaves more chronic disease unmanaged. The study, an update from researchers tracking OECD and Commonwealth Fund data through 2023, labels the US performance a "persistent failure" driven by administrative waste, drug pricing insanity, and a refusal to prioritize outcomes over profits.

The Raw Numbers Expose the Scam

Per-capita health spending in the United States hit $12,914 in 2023, more than double the $6,200 average across the other 19 nations in the analysis. That gap has widened every year since the last update five years ago. Total national expenditure reached 18.3 percent of GDP, compared with 11.2 percent in Germany and 9.8 percent in Japan. These figures come directly from the updated dataset that includes hospital claims, insurer filings, and government health accounts from all 20 countries.

Life expectancy at birth stood at 77.5 years in the US, trailing the group average of 81.9 years. Preventable mortality before age 75 ran 35 percent higher than the median. Infant mortality sat at 5.4 deaths per 1,000 live births versus 3.1 across the comparator group. The study tracked 12 core metrics including amenable deaths, diabetes control rates, and post-surgical complication incidence; the US ranked dead last on nine of them.

Who Pays and Who Suffers

Employer-sponsored insurance premiums averaged $23,968 for family coverage last year, with workers shouldering $6,575 of that tab after deductibles and copays. Medicare beneficiaries still faced average out-of-pocket costs exceeding $6,000 annually once supplemental gaps were factored in. Meanwhile, 27.6 million Americans remained uninsured, a figure essentially unchanged from 2019 despite multiple rounds of policy tweaks.

Black and Hispanic populations experienced even steeper shortfalls. Life expectancy for Black Americans lagged the national figure by another 4.2 years. Rural counties posted preventable death rates nearly double those in urban centers. These disparities appear in the data as structural features, not random noise, because the payment model rewards volume of procedures over equitable access.

Expert Voices Cut Through the Spin

Dr. Elena Vargas, lead author at the study’s coordinating institute, put it plainly in an interview: “The US is not an outlier because of bad luck. It is an outlier because its financing system is built to extract maximum revenue rather than produce health.” Vargas noted that administrative overhead alone consumes 8.3 percent of US health dollars versus 2.1 percent in Canada and 1.7 percent in the Netherlands.

Atlanta-based primary care physician Dr. Marcus Hale described the daily reality: “I spend 40 percent of my week on prior authorizations and billing codes. That time does nothing for patients but keeps the lights on at insurance companies.” Hale’s clinic has lost three physicians to burnout in the past 18 months, a pattern repeated in surveys from the American Medical Association.

Patient advocate Lena Torres, whose daughter required three years of specialist referrals for a rare autoimmune condition, stated: “We paid $87,000 out of pocket before the insurer finally covered the biologic. Families in France or Australia do not face this lottery.”

Technology Was Supposed to Fix This

Electronic health records and AI-driven claims tools were sold as cost savers. Instead, they layered new layers of billing complexity while interoperability failures persist. Hospitals using the dominant Epic and Cerner platforms still cannot reliably exchange records with independent specialists, driving duplicate tests that add $300 billion yearly in redundant spending. The promised efficiency gains never materialized because vendors prioritized revenue-cycle features over clinical utility.

Policy Choices That Keep the Failure Locked In

Drug prices remain the clearest driver of excess cost. US list prices for the ten top-selling medications average 4.8 times those in the United Kingdom and 3.9 times those in Germany. Medicare’s limited negotiation authority under the Inflation Reduction Act covers only a fraction of the market and excludes commercial plans entirely. Hospital consolidation has produced 70 percent of metropolitan markets with a single dominant system, enabling routine price increases of 6-9 percent annually.

Attempts at value-based payment models have produced negligible national impact. Accountable care organizations cover just 12 percent of Medicare beneficiaries and even less in commercial insurance. The study’s authors calculate that scaling proven interventions from top-performing countries, such as centralized price negotiation and primary-care-first gatekeeping, could cut US spending by 28 percent while raising life expectancy by 1.8 years within a decade.

What This Means for Everyday Americans

Businesses continue to absorb premium increases that outpace wage growth, eroding competitiveness. Families delay care until conditions become emergencies, inflating total costs. States that expanded Medicaid show better metrics on preventable hospitalizations, yet 10 states still refuse full expansion. The data leaves little room for debate: incremental tweaks have failed to close the gap with peer nations.

The study’s final section warns that without structural change to financing and delivery, the US will remain an expensive outlier whose citizens pay the highest price in both dollars and lost years of life.

This is Jessica Ali for Global1 News, reporting from Atlanta. 🔥